These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27388829)

  • 1. The Treatment of Superficial Femoral Artery In-Stent Restenosis: The Jury Is Still Out.
    Gray BH; Buchan JA
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1393-6. PubMed ID: 27388829
    [No Abstract]   [Full Text] [Related]  

  • 2. Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trial.
    Bosiers M; Deloose K; Callaert J; Verbist J; Hendriks J; Lauwers P; Schroë H; Lansink W; Scheinert D; Schmidt A; Zeller T; Beschorner U; Noory E; Torsello G; Austermann M; Peeters P
    J Endovasc Ther; 2015 Feb; 22(1):1-10. PubMed ID: 25775672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ISAR-PEBIS (Paclitaxel-Eluting Balloon Versus Conventional Balloon Angioplasty for In-Stent Restenosis of Superficial Femoral Artery): A Randomized Trial.
    Ott I; Cassese S; Groha P; Steppich B; Voll F; Hadamitzky M; Ibrahim T; Kufner S; Dewitz K; Wittmann T; Kasel AM; Laugwitz KL; Schunkert H; Kastrati A; Fusaro M
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28743787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.
    Miki K; Fujii K; Kawasaki D; Shibuya M; Fukunaga M; Imanaka T; Tamaru H; Sumiyoshi A; Nishimura M; Horimatsu T; Saita T; Okada K; Kimura T; Honda Y; Fitzgerald PJ; Masuyama T; Ishihara M
    J Endovasc Ther; 2016 Jun; 23(3):424-32. PubMed ID: 27044270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-Coated Balloon Versus Standard Balloon for Superficial Femoral Artery In-Stent Restenosis: The Randomized Femoral Artery In-Stent Restenosis (FAIR) Trial.
    Krankenberg H; Tübler T; Ingwersen M; Schlüter M; Scheinert D; Blessing E; Sixt S; Kieback A; Beschorner U; Zeller T
    Circulation; 2015 Dec; 132(23):2230-6. PubMed ID: 26446728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
    Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting balloons for the treatment of the superficial femoral artery in-stent restenosis: 2-year follow-up.
    Virga V; Stabile E; Biamino G; Salemme L; Cioppa A; Giugliano G; Tesorio T; Cota L; Popusoi G; Pucciarelli A; Esposito G; Trimarco B; Rubino P
    JACC Cardiovasc Interv; 2014 Apr; 7(4):411-5. PubMed ID: 24630884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
    Grotti S; Liistro F; Angioli P; Ducci K; Falsini G; Porto I; Ricci L; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    J Endovasc Ther; 2016 Feb; 23(1):52-7. PubMed ID: 26511896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Percutaneous Therapies for Peripheral Artery Disease: Drug-Coated Balloons.
    Al-Bawardy RF; Waldo SW; Rosenfield K
    Curr Cardiol Rep; 2017 Aug; 19(10):99. PubMed ID: 28840466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trans-radial treatment of in-stent restenosis of the superficial femoral artery--the importance of case selection.
    Casserly IP
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):499. PubMed ID: 19681127
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathophysiology of superficial femoral artery in-stent restenosis.
    Yahagi K; Otsuka F; Sakakura K; Sanchez OD; Kutys R; Ladich E; Kolodgie FD; Virmani R; Joner M
    J Cardiovasc Surg (Torino); 2014 Jun; 55(3):307-23. PubMed ID: 24755699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions.
    Dick P; Wallner H; Sabeti S; Loewe C; Mlekusch W; Lammer J; Koppensteiner R; Minar E; Schillinger M
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1090-5. PubMed ID: 19859954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A network meta-analysis of randomized controlled trials comparing treatment modalities for de novo superficial femoral artery occlusive lesions.
    Antonopoulos CN; Mylonas SN; Moulakakis KG; Sergentanis TN; Sfyroeras GS; Lazaris AM; Kakisis JD; Vasdekis SN
    J Vasc Surg; 2017 Jan; 65(1):234-245.e11. PubMed ID: 27865639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Biodegradable Igaki-Tamai Scaffold After Drug-Eluting Balloon Treatment of De Novo Superficial Femoral Artery Lesions: The GAIA-DEB Study.
    Werner M; Schmidt A; Scheinert S; Banning-Eichenseer U; Ulrich M; Bausback Y; Steiner S; Scheinert D
    J Endovasc Ther; 2016 Feb; 23(1):92-7. PubMed ID: 26620399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results with the Palmaz stent in the superficial femoral artery.
    Bergeron P; Pinot JJ; Poyen V; Benichou H; Khanoyan P; Rudondy P; Wang Y; Chiarandini S; el Hussein R; Rieu R
    J Endovasc Surg; 1995 May; 2(2):161-7. PubMed ID: 9234129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of endovascular treatment strategies on in-stent restenosis of femoropopliteal artery lesions].
    Fu WG; Yue JN
    Zhonghua Wai Ke Za Zhi; 2016 Aug; 54(8):586-90. PubMed ID: 27502131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis.
    Kawamura Y; Ishii H; Aoyama T; Tanaka M; Takahashi H; Kumada Y; Toriyama T; Murohara T
    J Vasc Surg; 2009 Nov; 50(5):1057-62. PubMed ID: 19782527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes of the Viabahn stent in the treatment of in-stent restenosis in the superficial femoral artery.
    Gorgani F; Telis A; Narakathu N; LaBarbera M; Babaev A
    J Invasive Cardiol; 2013 Dec; 25(12):670-4. PubMed ID: 24296388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel-coated versus uncoated balloon angioplasty for femoropopliteal artery in-stent restenosis.
    Wu R; Li Z; Wang M; Chang G; Yao C; Wang S
    Int J Surg; 2017 Jun; 42():72-82. PubMed ID: 28461145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How should I treat a restenosis after superficial femoral artery stenting?
    Fusaro M; Cassese S; Byrne RA
    EuroIntervention; 2013 Mar; 8(11):1342-5. PubMed ID: 23538161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.